We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTXR icon
3851
Citius Pharmaceuticals
CTXR
$15.6M
$70K ﹤0.01%
+1,572
New +$62.1K
LYRA
3852
DELISTED
LYRA THERAPEUTICS INC
LYRA
$70K ﹤0.01%
350
-690
-66% -$152K
EQOS
3853
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$70K ﹤0.01%
31,200
-244,089
-89% -$463K
UNAM
3854
DELISTED
Unico American Corp
UNAM
$68K ﹤0.01%
23,337
-200
-0.8% -$610
PSTV icon
3855
Plus Therapeutics
PSTV
$26.6M
$67K ﹤0.01%
180
-371
-67% -$141K
QNRX
3856
Quoin Pharmaceuticals
QNRX
$8.94M
$67K ﹤0.01%
10
-6
-38% -$44.8K
SNDL icon
3857
Sundial Growers
SNDL
$320M
$67K ﹤0.01%
9,523
AMBR
3858
Amber International Holding Ltd
AMBR
$130M
$67K ﹤0.01%
+5,670
New +$162K
CNTG
3859
DELISTED
Centogene N.V. Common Shares
CNTG
$67K ﹤0.01%
15,900
-32,568
-67% -$137K
EVK
3860
DELISTED
Ever-Glory International Group, Inc.
EVK
$67K ﹤0.01%
36,000
-4,400
-11% -$8.37K
IMH
3861
DELISTED
Impac Mortgage Holdings Inc.
IMH
$67K ﹤0.01%
89,971
-300
-0.3% -$259
TMDI
3862
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$66K ﹤0.01%
125,647
-141,184
-53% -$81.9K
LGL.WS
3863
DELISTED
LGL Group Inc Warrants
LGL.WS
$65K ﹤0.01%
125,259
-16,500
-12% -$9.92K
MDRR
3864
Medalist Diversified Inc
MDRR
$18.6M
$65K ﹤0.01%
3,850
+2,419
+169% +$40.5K
ASTC icon
3865
Astrotech Corp
ASTC
$13.1M
$64K ﹤0.01%
2,953
-11,748
-80% -$241K
PRHI
3866
Presurance Holdings
PRHI
$21.2M
$64K ﹤0.01%
3,857
-1,743
-31% -$28.7K
DOMH icon
3867
Dominari Holdings
DOMH
$57.4M
$64K ﹤0.01%
8,376
-4,853
-37% -$38.6K
ELEV
3868
DELISTED
Elevation Oncology
ELEV
$64K ﹤0.01%
25,400
+8,800
+53% +$35.3K
ASLN
3869
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$64K ﹤0.01%
+1,765
New +$65.6K
ACER
3870
DELISTED
Acer Therapeutics Inc
ACER
$64K ﹤0.01%
22,000
+4,600
+26% +$11.1K
DBTX
3871
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$64K ﹤0.01%
20,915
-29,985
-59% -$115K
BDR
3872
DELISTED
Blonder Tongue Laboratories Inc
BDR
$64K ﹤0.01%
99,449
-56,513
-36% -$30.4K
MTC icon
3873
MMTec
MTC
$404M
$63K ﹤0.01%
1,277
-293
-19% -$14.1K
VIVE
3874
DELISTED
VIVEVE MED INC
VIVE
$63K ﹤0.01%
59,449
+1,749
+3% +$1.75K
CHNR icon
3875
China Natural Resources
CHNR
$4.55M
$62K ﹤0.01%
1,615
-5,515
-77% -$197K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.